Design of a C/EBP-specific, dominant-negative bZIP protein with both inhibitory and gain-of-function properties

被引:52
|
作者
Olive, M
Williams, SC
Dezan, C
Johnson, PF
Vinson, C
机构
[1] NCI, BIOCHEM LAB, BETHESDA, MD 20892 USA
[2] NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, FREDERICK, MD 21702 USA
关键词
D O I
10.1074/jbc.271.4.2040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have developed a bZIP protein, GBF-F, with both dominant-negative (DN) and gain-of-function properties, GBF-F is a chimera consisting of two components: the DNA binding (basic) region from the plant bZIP protein GBF-1 (GBF) and a leucine zipper (F) designed to preferentially heterodimerize with the C/EBP alpha leucine zipper. Biochemical studies show that GBF-F preferentially forms heterodimers with C/EBP alpha and thus binds a chimeric DNA sequence composed of the half-sites recognized by the C/EBP and GBF basic regions. Transient transfections in HepG2 hepatoma cells show that both components of GBF-F are necessary for inhibition of C/EBP alpha transactivation. When the C/EBP alpha leucine zipper is replaced with that of either GCN4 or VBP, the resulting protein can transactivate a C/EBP cis-element but is not inhibited by GBF-F, indicating that the specificity of dominant-negative action is determined by the leucine zipper. All known members of the C/EBP family contain similar leucine zipper regions and are inhibited by GBF-F, GBF-F also exhibits gain-of-function properties, since, with the essential cooperation of a C/EBP family member, it can transactivate a promoter containing the chimeric C/EBP\GBF site. This protein therefore has potential utility both as a dominant-negative inhibitor of C/EBP function and as an activator protein with novel DNA sequence specificity.
引用
收藏
页码:2040 / 2047
页数:8
相关论文
共 17 条
  • [1] Mutant p53 oncogenicity: dominant-negative or gain-of-function?
    Stein, Yan
    Aloni-Grinstein, Ronit
    Rotter, Varda
    CARCINOGENESIS, 2020, 41 (12) : 1635 - 1647
  • [2] Loss-of-function, gain-of-function and dominant-negative mutations have profoundly different effects on protein structure
    Gerasimavicius, Lukas
    Livesey, Benjamin J.
    Marsh, Joseph A.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [3] Loss-of-function, gain-of-function and dominant-negative mutations have profoundly different effects on protein structure
    Lukas Gerasimavicius
    Benjamin J. Livesey
    Joseph A. Marsh
    Nature Communications, 13
  • [4] Pharmacological manipulation of gain-of-function and dominant-negative mechanisms in rhodopsin retinitis pigmentosa
    Mendes, Hugo F.
    Cheetham, Michael E.
    HUMAN MOLECULAR GENETICS, 2008, 17 (19) : 3043 - 3054
  • [5] Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities
    Iyer, Swathi V.
    Parrales, Alejandro
    Begani, Priya
    Narkar, Akshay
    Adhikari, Amit S.
    Martinez, Luis A.
    Iwakuma, Tomoo
    ONCOTARGET, 2016, 7 (05) : 5401 - 5415
  • [6] HETEROZYGOUS FRAMESHIFT MUTATIONS OF TP53 IN HUMAN BREAST CANCER CAUSE DOMINANT-NEGATIVE AND GAIN-OF-FUNCTION EFFECTS THROUGH PROTEIN AGGREGATION
    Xu, J.
    Couceiro, J.
    Rousseau, F.
    Schymkowitz, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 56 - 56
  • [7] p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect
    Blagosklonny, MV
    FASEB JOURNAL, 2000, 14 (13): : 1901 - 1907
  • [8] Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia
    Pabst, T
    Mueller, BU
    Zhang, P
    Radomska, HS
    Narravula, S
    Schnittger, S
    Behre, G
    Hiddemann, W
    Tenen, DG
    NATURE GENETICS, 2001, 27 (03) : 263 - 270
  • [9] Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia
    Thomas Pabst
    Beatrice U. Mueller
    Pu Zhang
    Hanna S. Radomska
    Sailaja Narravula
    Susanne Schnittger
    Gerhard Behre
    Wolfgang Hiddemann
    Daniel G. Tenen
    Nature Genetics, 2001, 27 : 263 - 270
  • [10] Mutant Trp53R172H has gain-of-function or dominant-negative effects in response to hematopoietic stressors in mice
    Liu, Tuoen
    Ahmed, Tanzir
    Alberti, Michael O.
    Wadugu, Brian A.
    Shao, Jin
    Grieb, Sarah
    Przybyl, Grace
    Ndonwi, Matthew
    Walter, Matthew J.
    CANCER RESEARCH, 2022, 82 (12)